← Back to headlines
Merck Animal Health to Acquire Biodevice Developer TARGAN
Merck Animal Health has announced its intention to acquire TARGAN, a developer of biodevices. This acquisition is expected to expand Merck's portfolio and capabilities within the animal health technology sector.
11 Jun, 11:36 — 11 Jun, 11:36
Sources
Showing 1 of 1 sources
